- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Amy Abernethy on Improving Data Usage at the Point of Care
Data needs to be more organized so it is more available and useful at the point of care, said Amy Abernethy, MD, PhD, the chief medical officer, chief scientific officer, and senior vice president of oncology at Flatiron Health.
Transcript (slightly modified)
With all the data now available, how can we ensure that it is used at the point of care to improve care delivery?
There’s so much data available. First of all, it needs to be cleaned up, so that by the time the data gets back to doctor and patient, it’s something that’s sensible. So, in order to make it available and useful for a point of care, it needs to be cleaned up and put into order. It needs to be analyzed and information needs to be presented to doctors and patients directly in the electronic health record or in dashboards that summarize, for example, what treatments patients have been receiving and how patients that look like this person sitting in front of me, have fared on Treatment A versus Treatment B.
So, that set of activities which include data, cleaning and organization, as well as getting to the point of having analyses we can rely on and being presented in dashboards and other methods to make is easy at point-of-care, is going to be the way that data starts to change care. The first steps are there but I think we’ve got a long way to go.
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
